5′-nucleotidase activity is altered by hypo- and hyperthyroidism in platelets from adult rats

Platelets

Volumn 16, Issue 1, 2005, Pages 25-30

  Bruno, Alessandra Nejar ^a   Pochmann, Daniela ^a   Ricachenevsky, Felipe Klein ^a   Bonan, Carla Denise ^b   Barreto Chaves, Maria Luiza M ^c   Sarkis, João José Freitas ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

5 nucleotidase; Adenosine; Hyperthyroidism; Hypothyroidism; Platelets

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; LEVOTHYROXINE; NUCLEOTIDE; THIAMAZOLE; THYROXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE SUBSTITUTION; HYDROLYSIS KINETICS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; THROMBOCYTE; THYROIDECTOMY; ANIMAL; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALIA;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; RATS; RATS, WISTAR; THYROXINE;

EID: 12244277430     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953710042000260164     Document Type: Article

References (33)

1. Honda H, Iwata T, Mochizuki T, Kogo H. Changes in vascular reactivity induced by acute hyperthyroidism in isolated rat aortae. Gen Pharmacol 2000;34:429-34.
2. Masunaga R, Nagasaka A, Nakai A, Kotake M, Sawai Y, Oda N, et al. Alteration of platelet aggregation in patients with thyroid disorders. Metabolism 1997;46:1128-31.
3. Mamiya S, Hagiwara M, Inoue S, Hidaka H. Thyroid hormones inhibit platelet function and myosin light chain kinase. J Biol Chem 1989;264:8575-9.
4. Erem C, Kavgaci H, Ersoz HO, Hacihasanoglu A, Ukinc K, Karti SS, et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 2003;57:78-81.
5. Wilson JD, Foster DW. The thyroid gland: Endocrinology 1985;682-815.
6. Coade SB, Pearson JD. Metabolism of adenine nucleotides in human blood. Circulation Res 1989;65:531-7.
7. Ralevic V, Burnstock G. Involvement of purinergic signaling in cardiovascular diseases. Drugs News Perspect 2003;16:133-40.
8. Williams M, Jarvis MF. Purinergic and pyrimidinergic receptors as potential drug targets. Biochem Pharmacol 2000;59:1173-85.
9. Soslau G, Youngprapakorn D. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta 1997;1355:131-40.
10. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001;86:222-32.
11. Burnstock G, Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 2000;295:862-9.
12. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier L, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997;99:1351-60.
13. Yegutkin G, Bodin P, Burnstock G. Effect of shear stress on the soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 2000;129:921-6.
14. Rongen GA, Floras JS, Lenders JW, Thien T, Smits P. Cardiovascular pharmacology of purines. Clin Sci (London) 1997;92:13-24.
15. Kawashima Y, Nagasawa T, Ninomiya H. Contribution of ecto-5′- nucleotidase to the inhibition of platelet aggregation by human endothelial cells. Blood 2000;96:2157-62.
16. Frassetto S, Dias RD, Sarkis JJF. Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets. Mol Cell Biochem 1993;129:47-55.
17. Bergamini C, Grazi E. Human platelets 5′-nucleotidase: a cell membrane ectoenzyme with a possible regulatory role in the aggregation reaction. Ital J Biochem 1980;29:238-50.
18. Pasini FL, Guideri F, Picano E, Parenti G, Petensen C, Varga A, et al. Increase in plasma adenosine during brain ischemia in man: A study during transient ischemic attacks and stroke. Brain Res Bull 2000;51:327-30.
19. Salin-Pascual RJ, Franco M, Garcia-Ferreiro R, Vazquez J, Suarez J, Sanchez L, et al. Differences in sleep variables, blood adenosine, and body temperature between hypothyroid and euthyroid rats before and after REM sleep deprivation. Sleep 1997;20:957-62.
20. Bruno AN, Da Silva RS, Bonan CD, Battastini AMO, Barreto-Chaves ML, Sarkis JJ. Hyperthyroidism modifies ecto-nucleotidase activities in synaptosomes from hippocampus and cerebral cortex of rats in different phases of development. Int J Dev Neurosci 2003;21:401-8.
21. Friberg P, Folkow B, Nordlander M. Structural adaptation of the rat left ventricle in response to changes in pressure and volume loads. Acta Physiol Scand 1985;125:67-79.
22. Pantos CI, Mourouzis IS, Tzeis SM, Malliopoulou V, Cokkinos DD, Asimacopoulos P, et al. Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts. J Cardiovasc Pharmacol 2000;36:384-9.
23. Calzà L, Aloe L, Giardinos L. Thyroid Hormone-Induced Plasticity in the Adult Rat brain. Brain Res Bull 1997;44:540-57.
24. Hantgan RR. A study of the kinetics of ADP-triggered platelet shape change. Blood 1984;64:896-906.
25. Tangen O, Berman HJ, Marfey P. A new technique for separation of blood platelets from plasma. Thromb Diath Haemorrh 1971;25:268-78.
26. +2-ATPase activity. Anal Biochem 1986;157:375-80.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
28. Carneiro-Ramos MS, Silva VB, Coutinho Jr MB, Battastini AMO, Sarkis JJF, Barreto-Chaves MLM. Thyroid Hormone stimulates 5′-ecto-nucleotidase of neonatal rat ventricular myocytes. Mol Cell Biochem In Press.
29. Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hyperthyroidism on α- and β-adrenergic receptor system and adrenergic responsiveness. Endocr Rev 1983;4:378-88.
30. Davis PJ, Davis FB. Nongenomic actions of thyroid hormone. Thyroid 1996;6:497-504.
31. Leonard JL, Farwell AP. Thyroid hormone-regulated actin polymerization in brain. Thyroid 1997;7:147-51.
32. Martin JV, Williams DB, Fitzgerald RM, Vonvoigtlander PF. Thyroid hormonal modulation of the binding and activity of the GABAA receptor complex of brain. Neuroscience 1996;73:705-13.
33. Sullivan PS, McDonald TP. Thyroxine suppresses thrombocytopoiesis and stimulates erythropoiesis in mice. Proc Soc Exp Biol Med 1992;201:271-7.